PE20091945A1 - Derivados de 3-oxoisoindolin-1-carboxamida - Google Patents

Derivados de 3-oxoisoindolin-1-carboxamida

Info

Publication number
PE20091945A1
PE20091945A1 PE2009000756A PE2009000756A PE20091945A1 PE 20091945 A1 PE20091945 A1 PE 20091945A1 PE 2009000756 A PE2009000756 A PE 2009000756A PE 2009000756 A PE2009000756 A PE 2009000756A PE 20091945 A1 PE20091945 A1 PE 20091945A1
Authority
PE
Peru
Prior art keywords
carboxamide
oxo
oxoisoindolin
compounds
isoindol
Prior art date
Application number
PE2009000756A
Other languages
English (en)
Inventor
Per I Arvidsson
Yevgeni Besidski
Gabor Csjernyik
Istvan Macsari
Linda I Nilsson
Tim Lange
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of PE20091945A1 publication Critical patent/PE20091945A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE 3-OXOISOINDOLIN-1-CARBOXAMIDA DE FORMULA (I) DONDE R1 ES H, ALQUILO(C1-C3), ALCOXI(C1-C3), CN, ENTRE OTROS; m ES 1 O 2; R2 Y R3 SON CADA UNO H, HALOALQUILO(C1-C4), HALOALCOXI(C1-C4), HALO, ENTRE OTROS; HET ES PIRIDINILO, PIRAZINILO, ISOXAZOLILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON X4, DONDE X4 ES HALO, CN, ALQUILO(C1-C3), ENTRE OTROS; L1 ES ALQUILENO(C1-C4) OPCIONALMENTE FLUORADO O HIDROXILADO; L2 ES ALQUILENO(C1-C3). SON COMPUESTOS PREFERIDOS: 3-OXO-2-(PIRIDIN-3-ILETIL)-N-[[4-(TRIFLUOROMETOXI)FENIL]METIL]-1H-ISOINDOL-1-CARBOXAMIDA, N-[(4-CLOROFENIL)METIL]-3-OXO-2-(2-PIRAZIN-2-ILETIL)-1H-ISOINDOL-1-CARBOXAMIDA, 4-HIDROXI-3-OXO-2-(2-(PIRIDIN-2-IL)ETIL)-N-(4-(TRIFLUOROMETOXI)BENCIL)ISOINDOLIN-1-CARBOXAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LOS CANALES DE SODIO NaV1.7 SIENDO UTILES EN EL TRATAMIENTO DEL DOLOR
PE2009000756A 2008-05-30 2009-05-29 Derivados de 3-oxoisoindolin-1-carboxamida PE20091945A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5731508P 2008-05-30 2008-05-30

Publications (1)

Publication Number Publication Date
PE20091945A1 true PE20091945A1 (es) 2010-01-28

Family

ID=41377343

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2009000756A PE20091945A1 (es) 2008-05-30 2009-05-29 Derivados de 3-oxoisoindolin-1-carboxamida

Country Status (6)

Country Link
AR (1) AR071955A1 (es)
CL (1) CL2009001329A1 (es)
PE (1) PE20091945A1 (es)
TW (1) TW201000461A (es)
UY (1) UY31852A (es)
WO (1) WO2009145718A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
EP2044019A1 (en) * 2006-07-12 2009-04-08 Astra Zeneca AB 3-oxoisoindoline-1-carboxamide derivatives as analgesic agents
TW200812962A (en) * 2006-07-12 2008-03-16 Astrazeneca Ab New compounds I/418
GB0705882D0 (en) * 2007-03-27 2007-05-02 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
TW201000461A (en) 2010-01-01
WO2009145718A1 (en) 2009-12-03
CL2009001329A1 (es) 2010-01-04
UY31852A (es) 2010-01-05
AR071955A1 (es) 2010-07-28

Similar Documents

Publication Publication Date Title
PE20141375A1 (es) Activadores de glucoquinasa
PE20120008A1 (es) Derivados de fenoxi bencenosulfonamida
PE20090641A1 (es) Amidas heterociclicas
PE20170705A1 (es) Nuevos compuestos como inhibidores de ret (reorganizado durante la transfeccion)
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
PE20140207A1 (es) Composiciones y metodos para modular el fxr
PE20081353A1 (es) Compuestos del inhibidor de fosfoinositida 3-cinasa
PE20121058A1 (es) Compuestos que modulan el receptor de androgenos
PE20180227A1 (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
PE20090434A1 (es) Derivados de sulfonil amida como inhibidores de quinasas
PE20081636A1 (es) Inhibidores de antranilamida para aurora quinasa
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
PE20131377A1 (es) Triazina-oxadiazoles
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
PE20081894A1 (es) Derivados de isoindolina 4'-o-sustituidos y composiciones que los comprenden y metodos para usarlos
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20091656A1 (es) Compuestos heterociclicos como inhibidores de la cinasa raf
PE20140868A1 (es) Antagonistas trpm8 y su uso en tratamientos
PE20071022A1 (es) Compuestos derivados de dibencilamina como inhibidores de la proteina de transferencia del colesteril ester (cept)
PE20071034A1 (es) Compuestos heterociclicos como inhibidores de cetp
PE20091974A1 (es) Derivados de indazoles sustituidos con fenil o piridinilo
PE20060079A1 (es) DERIVADOS DE PIRIDILO COMO ANTAGONISTAS DEL RECEPTOR mGlus5
RU2010142937A (ru) НОВЫЕ ПРОИЗВОДНЫЕ ПИПЕРИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ СТЕАРОИЛ-КоА ДЕСАТУРАЗЫ

Legal Events

Date Code Title Description
FA Abandonment or withdrawal